Oslo, Norway, May 5, 2025 – The Board of Directors of Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, hereby calls for the Annual General Meeting to be held at meeting room FORUM - Building H, Floor 0 in Gaustadalléen 21, Oslo, Norway at 10:00 CEST on May 26, 2025.
All documents regarding the Annual General Meeting are available at the Company’s website: https://nykode.com/investors/shareholder-meetings/
For further information, please see the Company’s website or contact the Company at IR@nykode.com
This information is subject to the disclosure requirements pursuant to sections 5-12 of the Norwegian Securities Trading Act.